TBPH - Theravance Biopharma, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate-1.2-1.18-4.69-3.7
Low Estimate-1.3-1.3-5.2-6.1
High Estimate-0.98-0.87-3.47-0.94
Year Ago EPS-0.76-1.1-3.99-4.69
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate14.37M15.15M58.93M113.74M
Low Estimate12.45M13.48M45.78M39.15M
High Estimate16M17M65M253.1M
Year Ago Sales23.48MN/A60.37M58.93M
Sales Growth (year/est)-38.80%N/A-2.40%93.00%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-1.2-1.15-1.06-1.19
EPS Actual-0.76-1.1-0.92-1.32
Difference0.440.050.14-0.13
Surprise %36.70%4.30%13.20%-10.90%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.2-1.18-4.69-3.7
7 Days Ago-1.2-1.18-4.69-3.7
30 Days Ago-1.14-1.13-4.5-3.47
60 Days Ago-1.14-1.13-4.47-3.47
90 Days Ago-1.09-1.06-4.48-2.76
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1121
Up Last 30 Days1121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/A2
Growth EstimatesTBPHIndustrySectorS&P 500
Current Qtr.-57.90%N/AN/A0.02
Next Qtr.-7.30%N/AN/A0.04
Current Year-17.50%N/AN/A0.05
Next Year21.10%N/AN/A0.11
Next 5 Years (per annum)104.90%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A